Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment (NCT05489068)
Adapting Intake Procedures to Improve Treatment Delivery in Addiction Treatment
🩺 Plain-English Summary (8th-Grade Level)
This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain personnel feedback on the feasibility of implementing MII into standard practice by having personnel from the addiction treatment study sites complete implementation climate measures before Motivational Interviewing (MI) training and post-clinical trial, as well as an individual interview on implementation feasibility post-trial.
Who can join: Review the eligibility criteria below.
Location: UNM Psychology Clinic — Albuquerque, New Mexico
Age range: 18 Years
🧪 Interventions in This Study
- Motivational Interviewing at Intake (MII) (BEHAVIORAL)
- Intake as Usual (IAU) (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- UNM Psychology Clinic — Albuquerque, New Mexico
📞 Contact the Study Coordinator
Phone: (505) 596-0578
Email: mhurlocker@unm.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Substance-Related Disorders
- Impact of Work Activity on SUD Outcomes — West Haven, Connecticut
- Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions — Eugene, Oregon
- Evaluating an Adverse Childhood Experience-Targeting Advocate Model of a Substance Use Prevention Program — Tinton Falls, New Jersey
- The Road to Recovery Initiative (R2RI) — Vancouver, British Columbia
- Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder — Richmond, Virginia
Explore by condition: All Substance-Related Disorders clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.